Pharm-Rx Dipyridamole USP

Product families

Other characteristics

Certifications & Compliance

United States Pharmacopeia (USP)

Markets

Healthcare & Pharma

Defination

Dipyridamole contains NLT 98.0% and NMT 102.0% of dipyridamole (C₂₄H₄₀N₈O₄ ), calculated on the dried basis.

Technology

Pharmaceuticals & Nutraceuticals

FDA Disclaimer

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Storage Information

Preserve in tight, light-resistant containers. Store at room temperature.

USP Reference Standards

USP Dipyridamole RS; USP Dipyridamole Related Compound A RS; 2,2′-{[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-; 2-yl]azanediyl}diethanol.; C₂₅H₄₀N₈O₂ 484.64; USP Dipyridamole Related Compound B RS; 2,2′,2′′,2′′′,2′′′′,2′′′′′-{[8-(Piperidin-1-yl)pyrimido[5,4-d]; pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol.; C₂₃H₄₀N₈O₆ 524.61; USP Dipyridamole Related Compound C RS; 2,2′-{[6-Chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]; pyrimidin-2-yl]azanediyl}diethanol.; C₂₀H₃₀ClN₇O₂ 435.95; USP Dipyridamole Related Compound D RS; 2,2′-({6-[(2-Hydroxyethyl)amino]-4,8-di(piperidin-1-yl); pyrimido[5,4-d]pyrimidin-2-yl}azanediyl)diethanol.; C₂₂H₃₆N₈O₃ 460.57; USP Dipyridamole Related Compound E RS; 2,2′,2′′,2′′′-{[6,8-Di(piperidin-1-yl)pyrimido[5,4-d]; pyrimidine-2,4-diyl]bis(azanetriyl)}tetraethanol.; C₂₄H₄₀N₈O₄ 504.63; USP Dipyridamole Related Compound F RS; 2,2′,2′′,2′′′-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-; yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl)); tetraethanol.; C₂₁H₃₆N₈O₅ 480.56

Show in full

Certifications and Compliance

United States Pharmacopeia (USP)